A surgical technology company
Making Surgical
History

We develop and globally distribute new-concept of surgical staplers and minimally invasive surgical devices.

Making Surgical History

About us

Since its establishment in April 2015, MEDITULIP Co., Ltd. has made remarkable achievements. Within one year since its establishment, it was selected for the TIPS program for the first time as a national university (September 2015), certified as a venture firm, registered four domestic patents, two international patents and filed eight international applications as well as two PCT application. We also registered 1 domestic patent and filed 1 PCT for a chemoport.

Moreover, we have obtained a factory site within the Osong Bio-Health Science Technopolis and plan to manufacture products in 2018.

Furthermore, we established MEDITULIP Global, Inc., a sales and market access company, to expedite the distribution of MEDITULIP products domestically and overseas and to import innovative products from abroad.

We will continue to make a second and a third "Surgical History" through continuous research and development based on our technological and development skills. MEDITULIP Co., Ltd. promises to serve as the light and the salt of the world, contributing to the human welfare through continuous innovation, services, and donations.

CEO of Meditulip Co., Ltd.
Thoracic Surgery Department Professor
Chungnam National University Hospital
Min-Woong Kang

Min-Woong Kang

MD/PhD, CEO of MEDITULIP Co., Ltd., Associate Professor, Chief of Thoracic Division, Department of Thoracic and Cardiovascular Surgery, Chungnam National University.

Professional Experience

  • National Institute of Medical Device Safety Information (NIDS): Advisor for medical device problems
  • KFDA: Advisory panel member of Medical device
  • Deputy of Director, Korean Society of Thoracic and Cardiovascular Surgery
  • Faculty member of ATCCS 2018, Hong Kong
  • Faculty member of ATSOP 2017, Singapore
  • Faculty member of 2nd Asian single port VATS surgery symposium
  • Member of The Korean Society for Thoracic and Cardiovascular Surgery
  • Member of The Korean Association for Lung Cancer Society
  • Member of The Korean society for Thoracic Surgical Oncology
  • Member of International Association for the Study of Lung Cancer
  • Member of Korean Association for the Study of Lung Cancer
  • Editorial Board member of Korean Association for the Study of Lung Cancer (Journal of Lung Cancer)
  • Scientific committee member of The Korean Society for Thoracic and Cardiovascular Surgery
  • Scientific committee member of The Korean Society for Thoracic Oncologic Surgery

Scientific Award

  • 2010 : Johnson and Johnson Medical award
  • 2009 : Scientific award of Korean Society for Thoracic and Cardiovascular Surgery.

Seungwan Sohn

CEO of MEDITULIP Global, Inc.

Professional Experience

  • Country Manager at Intuitive Surgical KOREA
  • Head of Strategic Planning and Head of Marketing at Samsung Medison
  • Marketing Director at Stryker KOREA
  • Senior Consultant at IBM GBS
  • Vice President at Nemo Partners

Education

  • BS degree in chemistry and MS in biochemistry from Seoul National University
  • MBA from Kellogg School of Management

IMPORTS

MediTulip Global will continue to develop distribution partnerships with emerging companies abroad to bring innovative products into the region.
What’s new

What’s new

Title Date
2016.05.03
Meditulip suggests a new paradigm for cancer operation

history

2018

  • Decemver

    MEDITULIP plant (GMP) opened

  • Decemver

    MEDITULIP Seoul Office opened

  • August

    국내 VC로부터 Series B (43억원) 투자 유치

  • July

    MEDITULIP Global, Inc. established 2018. 07. 26.

2016

  • December

    Obtained approval of moving into the land of Osong bio-Health Science Technopolis.

  • December

    Establishment of a branch office in China(Shanghai).

  • October

    Attracted Series A (about 1.5billion won) investment from Domestic VC.

  • July

    Agreed an investment contract with Chungcheongbuk-do along with Medical venture companies.

  • May

    Appeared on SBS CNBC 'The Eye of Enterprise that sees the Future Leader' + view

  • January

    Visited five major medical stapler manufacturing companies in China and discussed cooperation plans for international market expansion

  • January

    Selected as a Chungcheongbuk-do Province Innovative Medical Technology Value-creating Enterprise and developed a cooperation structure with the Osong Medical Innovation Foundation

2015

  • December

    Obtained a new technology patent for a surgical stapler that can secure tissues for pathological examination

  • November

    Held the Meditulip Co., Ltd. Medical Device Manufacturing TFT Workshop, which was participated in by institutions in cooperation, including the Osong Medical Innovation Foundation and Ji-Yool, a patent law firm

  • October

    Made industry–university cooperation and venture firm established by university faculty investment agreement (Chungnam Industry–University Cooperation – ActnerLab – Meditulip Co., Ltd.)

  • September

    Selected as a Chungbuk Industry–University Cooperation R&D Enterprise and for the TIPS program (first case for a company established by a national university faculty), and certified as a venture firm

  • August

    Opened the Osong office of Meditulip Co., Ltd.: Moved into the Osong Bio-Health Science Technopolis and qualified for various benefits under the Enforcement Decree of the Special Act on the Designation and Support of High-tech Medical Complexes (Presidential Decree No. 24454, March 23, 2013)

  • April

    Founded Meditulip Co., Ltd., a corporation established by a university faculty

2014

  • September

    Obtained a new technology patent for a surgical stapler with double blades